NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,021,000 | -11.3% | 12,082 | -2.7% | 0.07% | +428.6% |
| Q1 2022 | $1,151,000 | +0.7% | 12,419 | -5.0% | 0.01% | -81.3% |
| Q4 2021 | $1,143,000 | -25.6% | 13,069 | -30.4% | 0.08% | -29.2% |
| Q3 2021 | $1,536,000 | -23.2% | 18,782 | -14.4% | 0.11% | -24.3% |
| Q2 2021 | $2,001,000 | +4.9% | 21,932 | -1.7% | 0.14% | -4.1% |
| Q1 2021 | $1,907,000 | -8.5% | 22,308 | +1.0% | 0.15% | -14.6% |
| Q4 2020 | $2,085,000 | +10.0% | 22,082 | +1.3% | 0.17% | -1.7% |
| Q3 2020 | $1,896,000 | +2.9% | 21,803 | +3.3% | 0.17% | +3.0% |
| Q2 2020 | $1,843,000 | +5.6% | 21,103 | -0.3% | 0.17% | -40.7% |
| Q1 2020 | $1,745,000 | +34.3% | 21,165 | +54.3% | 0.28% | +37.0% |
| Q4 2019 | $1,299,000 | -37.9% | 13,719 | -43.0% | 0.21% | -32.7% |
| Q3 2019 | $2,093,000 | -3.2% | 24,080 | +1.7% | 0.31% | -3.1% |
| Q2 2019 | $2,162,000 | +8.5% | 23,680 | +14.2% | 0.32% | +18.1% |
| Q1 2019 | $1,993,000 | -26.9% | 20,730 | -34.7% | 0.27% | -34.6% |
| Q4 2018 | $2,725,000 | +3.3% | 31,762 | +3.7% | 0.41% | +63.9% |
| Q3 2018 | $2,638,000 | +4.1% | 30,618 | -8.7% | 0.25% | -30.4% |
| Q2 2018 | $2,533,000 | +5.1% | 33,533 | +12.5% | 0.36% | +7.4% |
| Q1 2018 | $2,410,000 | +26.4% | 29,812 | +31.3% | 0.34% | +10.1% |
| Q4 2017 | $1,906,000 | -13.2% | 22,697 | -11.3% | 0.31% | -3.2% |
| Q3 2017 | $2,197,000 | +3.6% | 25,592 | +0.7% | 0.32% | -2.8% |
| Q2 2017 | $2,121,000 | +9.8% | 25,414 | -2.3% | 0.32% | +10.2% |
| Q1 2017 | $1,931,000 | +0.1% | 26,003 | -1.8% | 0.30% | -6.3% |
| Q4 2016 | $1,929,000 | +18.7% | 26,483 | +28.7% | 0.32% | +27.5% |
| Q3 2016 | $1,625,000 | -4.3% | 20,583 | 0.0% | 0.25% | -9.2% |
| Q2 2016 | $1,698,000 | +12.7% | 20,583 | -1.1% | 0.27% | +115.9% |
| Q1 2016 | $1,507,000 | -17.7% | 20,808 | -2.2% | 0.13% | -57.1% |
| Q4 2015 | $1,831,000 | -3.2% | 21,282 | +3.4% | 0.29% | -1.7% |
| Q3 2015 | $1,891,000 | +4.6% | 20,575 | +11.9% | 0.30% | +7.6% |
| Q2 2015 | $1,808,000 | +737.0% | 18,386 | +738.4% | 0.28% | +694.3% |
| Q1 2015 | $216,000 | -39.3% | 2,193 | -43.0% | 0.04% | -47.8% |
| Q4 2014 | $356,000 | – | 3,845 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |